Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
Abstract Background Angiotensin-Converting Enzyme 2 (ACE2) is a crucial peptidase in human peptide hormone signaling, catalyzing the conversion of Angiotensin-II to Angiotensin-(1–7), which activates the Mas receptor and elicits vasodilation, increased blood flow, reduced inflammation, and decreased...
Saved in:
Main Authors: | Evelyn F Okal, Philip A. Romero, Pete Heinzelman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Biological Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13036-025-00482-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regular exercise in adolescents with ACE gene polymorphism helps preventing cardiovascular risk factors
by: Nivaldo de Jesus Silva Soares Junior, et al.
Published: (2025-02-01) -
Regular exercise in adolescents with ACE gene polymorphism helps preventing cardiovascular risk factors
by: Nivaldo de Jesus Silva Soares Junior, et al.
Published: (2025-02-01) -
Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
by: Roda Plakogiannis, et al.
Published: (2025-02-01) -
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy
by: Yishen Tian, et al.
Published: (2025-04-01) -
First evidence of immunomodulation of the renin-angiotensin system through substance P/neurokinin 1 receptor: a case and control study in hypertension and cardiac patients
by: Ibrahim M. Alanazi, et al.
Published: (2025-02-01)